![](/img/cover-not-exists.png)
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG
Hadji, Peyman, Aapro, Matti S., Body, Jean-Jacques, Gnant, Michael, Brandi, Maria Luisa, Reginster, Jean Yves, Zillikens, M. Carola, Glüer, Claus-C., de Villiers, Tobie, Baber, Rod, Roodman, G. David,Volume:
7
Language:
english
Journal:
Journal of Bone Oncology
DOI:
10.1016/j.jbo.2017.03.001
Date:
June, 2017
File:
PDF, 693 KB
english, 2017